Literature DB >> 24220169

Sterile inflammation after permanent distal MCA occlusion in hypertensive rats.

Karoline Möller1, Johannes Boltze2, Claudia Pösel3, Johannes Seeger4, Tobias Stahl5, Daniel-Christoph Wagner6.   

Abstract

The pathophysiology of stroke is governed by immune reactions within and remote from the injured brain. Hypertension, a major cause and comorbidity of stroke, entails systemic vascular inflammation and may influence poststroke immune responses. This aspect is, however, underestimated in previous studies. Here we aimed to delineate the sequence of cellular inflammation after stroke in spontaneously hypertensive (SH) rats. Spontaneously hypertensive rats were subjected to permanent middle cerebral artery occlusion and killed after 1 or 4 days. Immune cells of the peripheral blood and those which have infiltrated the injured brain were identified and quantified by flow cytometry. The spatial distribution of myeloid cells and T lymphocytes, and the infarct volume were assessed by histology. We observed a concerted infiltration of immune cells into the ischemic brain of SH rats. At day 1, primarily neutrophils, monocytes, macrophages, and myeloid dendritic cells entered the brain, whereas the situation at day 4 was dominated by microglia, macrophages, lymphatic dendritic cells, and T cells. Postischemic inflammation did not cause secondary tissue damage during the subacute stage of experimental stroke in SH rats. Considering the intrinsic vascular pathology of SH rats, our study validates this strain for further translational research in poststroke inflammation.

Entities:  

Mesh:

Year:  2013        PMID: 24220169      PMCID: PMC3915208          DOI: 10.1038/jcbfm.2013.199

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

Review 1.  Stroke and the immune system: from pathophysiology to new therapeutic strategies.

Authors:  Richard Macrez; Carine Ali; Olivier Toutirais; Brigitte Le Mauff; Gilles Defer; Ulrich Dirnagl; Denis Vivien
Journal:  Lancet Neurol       Date:  2011-05       Impact factor: 44.182

2.  The habitual, diverse and surmountable obstacles to human immunology research.

Authors:  Adrian C Hayday; Mark Peakman
Journal:  Nat Immunol       Date:  2008-06       Impact factor: 25.606

3.  Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats.

Authors:  Jin Zhou; Hiromichi Ando; Miroslava Macova; Jingtao Dou; Juan M Saavedra
Journal:  J Cereb Blood Flow Metab       Date:  2005-07       Impact factor: 6.200

Review 4.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

5.  Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats.

Authors:  Ute-Maria Riegelsberger; Alexander Deten; Claudia Pösel; Marietta Zille; Alexander Kranz; Johannes Boltze; Daniel-Christoph Wagner
Journal:  Exp Neurol       Date:  2010-11-16       Impact factor: 5.330

6.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

7.  CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.

Authors:  Beatriz Almolda; Manuela Costa; Maria Montoya; Berta González; Bernardo Castellano
Journal:  J Neuroimmunol       Date:  2009-02-26       Impact factor: 3.478

8.  Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

Authors:  Mélanie Lalancette-Hébert; Geneviève Gowing; Alain Simard; Yuan Cheng Weng; Jasna Kriz
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

9.  Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide.

Authors:  Deborah De Geyter; Wendy Stoop; Tine Zgavc; Sophie Sarre; Yvette Michotte; Jacques De Keyser; Ron Kooijman
Journal:  J Neuroinflammation       Date:  2012-05-30       Impact factor: 8.322

10.  On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity.

Authors:  Kevin L Legge; Randal K Gregg; Roberto Maldonado-Lopez; Lequn Li; Jacque C Caprio; Muriel Moser; Habib Zaghouani
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  14 in total

1.  Noise-induced hearing loss: Neuropathic pain via Ntrk1 signaling.

Authors:  Senthilvelan Manohar; Kimberly Dahar; Henry J Adler; Ding Dalian; Richard Salvi
Journal:  Mol Cell Neurosci       Date:  2016-07-26       Impact factor: 4.314

Review 2.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

3.  Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain.

Authors:  Claudia Pösel; Karoline Möller; Johannes Boltze; Daniel-Christoph Wagner; Gesa Weise
Journal:  J Vis Exp       Date:  2016-02-12       Impact factor: 1.355

Review 4.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

Review 5.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Authors:  María Isabel Cuartero; Juan de la Parra; Alicia García-Culebras; Iván Ballesteros; Ignacio Lizasoain; María Ángeles Moro
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 6.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

7.  Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats.

Authors:  Kai Diederich; Antje Schmidt; Carolin Beuker; Jan-Kolja Strecker; Daniel-Christoph Wagner; Johannes Boltze; Wolf-Rüdiger Schäbitz; Jens Minnerup
Journal:  Front Cell Neurosci       Date:  2014-12-04       Impact factor: 5.505

8.  Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat.

Authors:  Ursula I Tuor; Zonghang Zhao; Philip A Barber; Min Qiao
Journal:  BMC Neurosci       Date:  2016-05-26       Impact factor: 3.288

9.  Immunomodulation with Human Umbilical Cord Blood Stem Cells Ameliorates Ischemic Brain Injury - A Brain Transcriptome Profiling Analysis.

Authors:  Maple L Shiao; Ce Yuan; Andrew T Crane; Joseph P Voth; Mario Juliano; Laura L Hocum Stone; Zhenghong Nan; Ying Zhang; Nicole Kuzmin-Nichols; Paul R Sanberg; Andrew W Grande; Walter C Low
Journal:  Cell Transplant       Date:  2019-05-08       Impact factor: 4.064

10.  Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke.

Authors:  Karoline Möller; Claudia Pösel; Alexander Kranz; Isabell Schulz; Johanna Scheibe; Nadine Didwischus; Johannes Boltze; Gesa Weise; Daniel-Christoph Wagner
Journal:  Front Cell Neurosci       Date:  2015-11-27       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.